Cargando…
Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083173/ https://www.ncbi.nlm.nih.gov/pubmed/37032391 http://dx.doi.org/10.1038/s41408-023-00824-8 |
| _version_ | 1785021450802954240 |
|---|---|
| author | Alcheikh, Ahmad Perkins, Griffith B. Pucar, Phillippa A. Cecchin, Amelia Chai, Cheng Sheng Tunbridge, Matthew Akerman, Anouschka Aggarwal, Anupriya Milogiannakis, Vanessa Turville, Stuart Allen, Sharon Hissaria, Pravin Banovic, Tatjana Coates, P. Toby Ross, David M. |
| author_facet | Alcheikh, Ahmad Perkins, Griffith B. Pucar, Phillippa A. Cecchin, Amelia Chai, Cheng Sheng Tunbridge, Matthew Akerman, Anouschka Aggarwal, Anupriya Milogiannakis, Vanessa Turville, Stuart Allen, Sharon Hissaria, Pravin Banovic, Tatjana Coates, P. Toby Ross, David M. |
| author_sort | Alcheikh, Ahmad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10083173 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100831732023-04-11 Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients Alcheikh, Ahmad Perkins, Griffith B. Pucar, Phillippa A. Cecchin, Amelia Chai, Cheng Sheng Tunbridge, Matthew Akerman, Anouschka Aggarwal, Anupriya Milogiannakis, Vanessa Turville, Stuart Allen, Sharon Hissaria, Pravin Banovic, Tatjana Coates, P. Toby Ross, David M. Blood Cancer J Correspondence Nature Publishing Group UK 2023-04-10 /pmc/articles/PMC10083173/ /pubmed/37032391 http://dx.doi.org/10.1038/s41408-023-00824-8 Text en © Crown 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Alcheikh, Ahmad Perkins, Griffith B. Pucar, Phillippa A. Cecchin, Amelia Chai, Cheng Sheng Tunbridge, Matthew Akerman, Anouschka Aggarwal, Anupriya Milogiannakis, Vanessa Turville, Stuart Allen, Sharon Hissaria, Pravin Banovic, Tatjana Coates, P. Toby Ross, David M. Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_full | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_fullStr | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_full_unstemmed | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_short | Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients |
| title_sort | humoral and cellular immunity to sars-cov-2 ancestral and omicron ba.5 variants following vaccination in myelofibrosis patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083173/ https://www.ncbi.nlm.nih.gov/pubmed/37032391 http://dx.doi.org/10.1038/s41408-023-00824-8 |
| work_keys_str_mv | AT alcheikhahmad humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT perkinsgriffithb humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT pucarphillippaa humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT cecchinamelia humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT chaichengsheng humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT tunbridgematthew humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT akermananouschka humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT aggarwalanupriya humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT milogiannakisvanessa humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT turvillestuart humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT allensharon humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT hissariapravin humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT banovictatjana humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT coatesptoby humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients AT rossdavidm humoralandcellularimmunitytosarscov2ancestralandomicronba5variantsfollowingvaccinationinmyelofibrosispatients |